Fluorescence in situ hybridization as a diagnostic tool in malignant lymphomas

Histochemistry and Cell Biology

Volumn 108, Issue 4-5, 1997, Pages 391-402

  Siebert, Reiner ^a   Weber Matthiesen, Klaus ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CHROMOSOME BREAKAGE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; HODGKIN DISEASE; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, NON-HODGKIN; TRANSLOCATION, GENETIC;

EID: 0030808734     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004180050180     Document Type: Article

References (80)

1. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JD (1992) Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood 79:1796-1801
2. Bakhshi A, Wright JJ, Graninger W Seto M, Owens J, Cossman J, Jensen JP, Goldman P, Korsmeyer SJ (1987) Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci USA 84:2396-2400
3. Banks PM, Chan J, Cleary ML, Delsol G, Wolf-Peeters C de, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Warnke R (1992) Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16:637-640
4. Baron BW, Nucifora G, McCabe N, Espinosa R III, Le Beau MM, McKeithan TW (1993) Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc Natl Acad Sci USA 90:5262-5266
5. Bigoni F, Negrini M, Veronese ML, Cuneo A, Castoldi GL, Croce CM (1996). Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization. Oncogene 13:797-802
6. Boer CJ de, Loyson S, Kluin PM, Kluin-Nelemans HC, Schuuring E, Krieken JHJM van (1993) Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. Cancer Res 53:4148-4152
7. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM (1994) Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873-2877
8. Choi TK, Hollenbach PW, Pearson BE, Ueda RM, Weddell GN, Kurahara CG, Woodhouse CS, Kay RM, Loring JF (1993) Transgenic mice containing a human heavy chain immunoglobulin gene fragment cloned in a yeast artificial chromosome. Nature Genet 4:117-123
9. Cleary ML, Sklar J (1985) Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82: 7439-7443
10. Cleary ML, Galili N, Sklar J (1986) Detection of a second t(14;18) breakpoint cluster region in follicular lymphomas. J Exp Med 164:315-320
11. Coignet EJA, Schuuring E, Kibbelaar RE, Raap TK, Kleiverda KK, Bertheas MF, Wiegant J, Beverstock G, Kluin PM (1996) Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization. Blood 87: 1512-1519
12. Döhner H, Fischer K, Bentz M, Hansen K, Banner A, Cabot G, Diehl D, Schlenk R, Coy J, Stilgenbauer S, Volkmann M, Galle PR, Poustka A, Hunstein W, Lichter P (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85: 1580-1589
13. Döhner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz, M, Fischer K, Hunstein W, Lichter P (1997) 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 89:2516-2522
14. Gaidano G, Hauptschein RS, Parsa NZ, Offit K, Rao PH, Lenoir G, Knowles DM, Chaganti RSK, Dalla-Favera R (1992) Deletions involving two distinct regions of 6q in B-cell non-Hodgkin's lymphoma. Blood 80:1781-1787
15. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84:1361-1392
16. Johansson B, Mertens F, Mitelman F (1995) Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 86:3905-3914
17. Joos S, Haluska FG, Falk MH, Henglein B, Hameister H, Croce CM, Bornkamm GW (1992a) Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc. Cancer Res 52:6547-6552
18. Joos S, Falk MH, Lichter P, Haluska FG, Henglein B, Lenoir GM, Bornkamp GW (1992b) Variable brakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. Hum Mol Gen 1:625-632
19. Ladanyi M, Cavalchire G, Morris SW, Downing J, Filippa DA (1994) Reversed transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. Am J Pathol 145: 1296-1300
20. Lichter P, Ward DC (1990) Is non-isotopic in situ hybridization finally coming of age? Nature 345:93-95
21. Lichter P, Tang CC, Call K, Hermanson G, Evans GA, Housman D, Ward DC (1990) High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64-69
22. Lishner M, Kenet G, Lalkin A, Yarkoni S, Ben-Bassat H, Fejgin M, Rechavi G, Amiel A (1993) Fluorescent in situ hybridization for the detection of t(8;14) in Burkitt's lymphoma. Acta Haematol 90:186-189
23. LoCoco F, Gaidano G, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R (1993) p53 mutations are associated with histologic transformation of follicular lymphomas. Blood 82:2289-2295
24. Lu-Kuo JM, Le Paslier D, Weissenbach J, Chumakov I, Cohen D, Ward DC (1994) Construction of a YAC contig and a STS map spanning at least seven megabasepairs in chromosome 5q34-35. Hum Mol Genet 3:99-106
25. Mason DY, Bastard C, Rimokh R (1990) CD30 positive large cell lymphomas (Ki1 lymphoma) are associated with a chromosomal translocation involving 5q35. Br J Hematol 74:161-168
26. Matthew P, Sanger WG, Weisenburger DD, Valentine M, Valentine V, Pickering D, Higgins C, Hess M, Cui X, Scrivastava DK, Morris SW (1997) Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization. Blood 89:1678-1685
27. Meeker RC, Grimaldi JC, O'Rourke R, Louie E, Juliusson G, Einhorn S (1989). An additional breakpoint region in the BCL-1 locus associated with the t(11;14)(q13;q32) translocation of B-lymphocytic malignancy. Blood 74:1801-1806
28. Meeker TC, Sellers W, Harvey R, Withers D, Carey K, Xiao H, Block AM, Dadey B, Han T (1991). Cloning of the t(11;14)(q13;q32) translocation breakpoints from two human leukemia cell lines. Leukemia 5:733-737
29. Michaux L, Mecucci C, Stul M, Wlodarska I, Hernandez JM, Meeus P, Michaux P, Scheiff JM, Noel H, Louwagi A, Criel A, Boogaerts M, Orshoven A van, Cassiman JJ, Berghe H van den (1996) BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders. Genes Chromosom Cancer 15:38-47
30. Mitelman F (1994) Catalog of chromosome aberrations in cancer, 5th edn. Wiley Liss, New York
31. Monteil M, Callanan M, Dascalescu C, Sotto JJ, Leroux D (1996) Molecular diagnosis of t(11;14) in mantle cell lymphoma using two-color interphase fluorescence in situ hybridization. Br J Hematol 93:656-660
32. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT (1994) Fusion of a kinase gene, ALK, to a nucleolar gene, NPM, in non-Hodgkin's lymphoma. Science 163:1281-1284
33. Motokura T, Arnold A (1992) Cyclins and oncogenesis. Biochim Biophys Acta 1155:63-78
34. Motokura T, Bloom T, Kim HG, Jüppner H, Ruderman JV, Kronenberg HM, Arnold A (1991) A novel cyclin encoded by a BCL-1 linked candidate oncogene. Nature 350:512-515
35. Neri A, Barriga F, Knowles DM, Magrath I, Dalla-Favera R (1988) Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 83:2748-2752
36. Offit K, Chaganti RSK (1991) Chromosomal aberrations in non-Hodgkin's lymphoma - biologic and clinical correlations. Haematol Oncol Clin North Am 5:853-869
37. Offit K (1992) Chromosome analysis in the management of patients with non-Hodgkin's lymphoma. Leuk Lymphoma 7: 275-282
38. Offit K, Parsa NZ, Gaidano G, Filippa DA, Louie D, Pan D, Jhanwar SC, Dalla-Favera R, Chaganti RSK (1993) 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 82:2157-2162
39. Offit K, LoCoco F, Louie D, Parsa NZ, Leung D, Portlock C, Ye BH, Lista F, Filippa DA, Rosenbaum A, Ladanyi M, Jhanwar S, Dalla-Favera R, Chaganti RSK (1994a) Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 331:74-80
40. Offit K, Louie DC, Parsa NZ, Filippa D, Gangi M, Siebert R, Chaganti RSK (1994b) Clinical and morphological features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood 83:2611-2618
41. Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AC (1995) Large-cell anaplastic lymphoma-specific translocation (t[2;5][p23;q35]) in Hodgkin's disease: indication of a commmon pathogenesis. Lancet 345:87-90
42. Pelicci PG, Knowles DM, Magrath I, Dalla-Favera R (1986) Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 83:2984-2988
43. Pinkel D, Straume T, Gray JW (1986) Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83:2934-2938
44. Poetsch M, Weber-Matthiesen K, Plendl HJ, Grote W, Schlegelberger B (1996) Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast artificial chromosome probes in follicular lymphoma and non-neoplastic lymphoproliferation. J Clin Oncol 14:963-969
45. Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372:143-149
46. Raffeld M, Jaffe ES (1991) bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 78:259-263
47. Ried T, Lengauer T, Cremer T, Wiegant J, Raap AK, Ploeg M van der, Groitl P, Lipp M (1992) Specific metaphase and interphase detection of the breakpoint region in 8q24 of Burkitt lymphoma cells by triple-color fluorescence in situ hybridization. Genes Chromosom Cancer 4:69-74
48. Rimokh R, Berger F, Delsol G, Digonnet I, Rouault JP, Tigaud JD, Gadoux M, Coiffier B, Bryon PA, Magaud JP (1994) Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 7:1871-1875
49. Schlegelberger B, Feller AC (1996) Classification of peripheral T-cell lymphomas: cytogenetic findings support the updated Kiel classification. Leuk Lymphoma 20:411-416
50. Schlegelberger B, Himmler A, Gödde E, Grote W, Feller AC, Lennert K (1994a) Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 83:505-511
51. Schlegelberger B, Zhang Y, Weber-Matthiesen K, Grote W (1994b) Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined interphase and metaphase cytogenetics. Blood 84:2640-2648
52. Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A, Guttierez M, Levine P, Magrath I (1991) Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 77:1516-1526
53. Siebert R, Willers CP, Opalka B (1996) Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma. Leuk Lymphoma 23:505-520
54. Siebert R, Weber-Matthiesen K, Matthiesen P, Zhang Y, Schlegelberger B (1997) Re: B-cell non-Hodgkin's lymphoma: evidence for the t(14;18) translocation in all hematopoietic cell lineages. J Natl Cancer Inst 89:93-94
55. Silverman GA, Green ED, Young RL, Jockel JI, Domer PH, Korsmeyer SJ (1990) Meiotic recombination between yeast artificial chromosome yields a single clone containing the entire BCL2 protooncogene. Proc Natl Acad Sci USA 87:9913-9917
56. Szepetowski P, Perucca-Lostanlen D, Grosgeorge J, LePaslier D, Brownstein BH, Carle GF, Gaudray P (1995) Description of a 700-kb yeast artificial chromosome contog containing the BCL1 translocation breakpoint region at 11q13. Cytogenet Cell Genet 69:101-107
57. Taniwaki M, Nishida K, Ueda Y, Misawa S, Nagai M, Tagawa S, Yamagami T, Sugiyama H, Abe M, Fukuhara S, Kashima K (1995) Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization. Blood 85: 3223-3228
58. The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. Blood 89: 3909-3918
59. Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigrogne Y, Kunlin A, Monconduit M, Bastard C (1994) Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84:1043-1049
60. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowel PC, Croce CM (1984) Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224:1403-1406
61. Tsujimoto Y, Jaffe E, Cossman J, Nowell PC, Croce CM (1985) Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 315:340-343
62. Ueda Y, Matsuda F, Misawa S, Taniwaki M (1996) Tumor-specific rearrangements of the immunoglobulin heavy-chain gene in B-cell non-Hodgkin's lymphoma detected by in situ hybridization. Blood 87:292-298
63. Veronese ML, Ohta M, Finan J, Nowell PC, Croce CM (1995) Detection of myc translocations in lymphoma cells by fluorescence in situ hybridization with yeast artificial chromosomes. Blood 85:2132-2138
64. Weber-Matthiesen K (1996) Fluorescence immunophenotyping and interphase cytogenetics as a tool for investigation of neoplasms (FICTION): combined in situ hybridization and fluorescence immunophenotyping. In: Clark M (ed.) In situ hybridization. Chapman and Hall, Weinheim, pp 67-90
65. Weber-Matthiesen K, Winkemann M, Müller-Hermelink A, Schlegelberger B, Grote W (1992) Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem 40:171-175
66. Weber-Matthiesen K, Deerberg J, Müller-Hermelink A, Schlegelberger B, Grote W (1993a) Rapid immunophenotypic characterization of chromosomally aberrant cells by the new FICTION method. Cytogenet Cell Genet 63:123-125
67. Weber-Matthiesen K, Pressl S, Schlegelberger B, Grote W (1993b) Combined immunophenotyping and interphase cytogenetics on cryostat section by the new FICTION method. Leukemia 7: 646-649
68. Weber-Matthiesen K, Müller-Hermelink A, Deerberg J, Scherthan H, Schlegelberger B, Grote W (1993c) Discrimination of distinct subpopulations within a tumor using combined double immunophenotyping and interphase cytogenetics. J Histochem Cytochem 41:1641-1644
69. Weber-Matthiesen K, Deerberg J, Poetsch M, Grote W, Schlegelberger B (1995a) Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 86:1464-1468
70. Weber-Matthiesen K, Deerberg J, Poetsch M, Grote W, Schlegelberger B (1995b) Clarification of dubious karyotypes in Hodgkin's disease by simultaneous fluorescence immunophenotyping and interphase cytogenetics (FICTION). Cytogenet Cell Genet 70:243-245
71. Weber-Matthiesen K, Winkemann M, Grote W, Schlegelberger B (1995c) Kappa and lambda positive cells in centroblastic-centrocytic lymphoma (follicular lymphoma) may share the same secondary chromosome aberration: reflections on early lymphoma development. Genes Chromosom Cancer 14:22-27
72. Weber-Matthiesen K, Deerberg-Wittram J, Rosenwald A, Poetsch M, Grote W, Schlegelberger B (1996) The translocation t(2;5) is not a primary event in Hodgkin's disease: simultaneous immunophenotyping and interphase cytogenetics. Am J Pathol 149:463-468
73. Weisenburger DD, Armitage JO (1996) Mantle cell lymphoma - an entity comes of age. Blood 87:4483-4494
74. Weiss LM, Lopategui JR, Sun LH, Kamel OW, Koo CH, Glackin C (1995) Absence of the t(2;5) in Hodgkin's disease. Blood 85:2845-2847
75. Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M (1995) Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype and in Hodgkin's disease. Blood 86: 2321-2328
76. Wotherspoon AC, Finn TM, Isaacson PG (1995) Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 85:2000-2004
77. Yee HT, Ponzoni M, Merson A, Goldstein M, Scarpa A, Chilosi M, Menestrina F, Pittaluga S, De Wolf-Peeters C, Shiota M, Mori S, Frizzera G, Inghiami G (1996) Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood 87: 1081-1088
78. Zech L, Haglund U, Nilsson K, Klein G (1976) Characteristic chromosomal abnormalities in biopsies and lymphoid cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17:47-56
79. Zhang Y, Weber-Matthiesen K, Siebert R, Matthiesen P, Schlegelberger B (1997) Frequent deletions of 6q23-24 in B-cell non-Hodgkin's lymphomas detected by fluorescence in situ hybridization. Genes Chromosom Cancer 18:310-313
80. Zucca E, Soldati G, Schlegelberger B, Booth MJ, Weber-Matthiesen K, Cavalli F, Cotter FE (1995) Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma. Br J Hematol 89:665-668